Drugs · acquisition-cost intelligence
GAVILYTE G TM
polyethylene glycol-3350 and Electrolytes· ingredient polyethylene glycol 3350Electrolyte solutions· POLYETHYLENE GLYCOL 3350 236 g/274.31g; POTASSIUM CHLORIDE 2.97 g/274.31g; POLYETHYLENE GLYCOL 3350 236 g/4L; POTASSIUM CHLORATE 2.97 g/4L; POLYETHYLENE GLYCOL 3350 236 g/4L; POTASSIUM CHLORIDE 2.97 g/4L
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.00465
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other polyethylene glycol 3350 products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| GaviLyte - C TM | $0.00373 | −$0.00090 |
| GAVILYTE-N | $0.00569 | +$0.00100 |
| basic care clearlax | $0.02458 | +$0.01990 |
| SUFLAVE | $61.64 | +$61.64 |
Medicare Part D coverage · CY2026
On 323 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.